Amplifying equity investing in innovative client solutions
Our alternative equity capabilities combine our deep history of active management with innovative product structures that today’s investors demand. We manage specialised equity strategies including growth equities seeking to deliver enhanced returns and long/short strategies targeting consistent absolute returns regardless of market direction.
Alternative Equities
Name
About this product
A biotechnology strategy that seeks to leverage a disciplined approach to identify compelling opportunities across the biotech landscape in both public and private investments.
For investors targeting positive returns in all market conditions from a long/short equity strategy with typically low sensitivity to markets.
